TRODELVY

sacituzumab govitecan · Gilead Sciences, Inc.

Drug timelines are a Plus or Pro feature.

44 regulatory and trial events tracked for TRODELVY, covering 2020-04-22 to 2026-07-28. Get the full timeline:

Most recent: EMA Authorised: Trodelvy (sacituzumab govitecan) — Gilead Sciences Ireland UC